Oncology-Based In-vivo CRO Market Size & Forecast 2025-2035

The global Oncology-Based In-vivo CRO Market is projected to grow from USD 1.3 billion in 2025 to USD 3.4 billion by 2035, at a CAGR of 10.4%. Efficacy Studies will dominate with a 33.2% market share, while Lung Cancer will lead with a 22.2% share.

July 04, 2025

Anurag Sharma

250 Pages

Cite this Report

Oncology-Based In-vivo CRO Market

https://www.futuremarketinsights.com/reports/oncology-based-in-vivo-cro-market

License

Buy Now

Summary ToC Companies

Key Players

ICON plc

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Oncology-Based In-vivo CRO Market

Thank you!

You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.

Oncology-Based In-vivo CRO Market

Key Players

Similar Industry Reports